{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:59Z","timestamp":1792784939805,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ayuda de Biomedicina 2019\u2019 Fundaci\u00f3n Domingo Mart\u00ednez","id":[{"id":"https:\/\/ror.org\/035cp1g70","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    PPAR\u03b3 coactivator 1 alpha (PGC1\u03b1) is a master transcriptional coregulator of metabolism, and its activity mirrors many of the effects of hypoxia signaling in prostate cancer (PCa). Whereas PGC1\u03b1 restrains PCa progression through its association with the estrogen-related receptor alpha (ERR\u03b1) and is a predictor of better patient outcome, hypoxia signaling is associated with poor prognosis. However, their interplay in PCa remains poorly understood. Here we show that the PGC1\u03b1\/ERR\u03b1 complex reduces the protein levels of Hypoxia Inducible transcription Factor alpha (HIF\u03b1). Moreover, loss of PGC1\u03b1 is associated with the establishment of an autocrine pseudohypoxic state. Mechanistically, the transcriptional complex formed by PGC1\u03b1 and ERR\u03b1 binds to the\n                    <jats:italic>EGLN1<\/jats:italic>\n                    promoter, induces PHD2 expression, and triggers canonical HIF\u03b1 proteasomal degradation. This mechanism is oxygen-dependent and thus is prevented under severe hypoxia. Importantly, this regulatory axis provides a new component to the tumor-suppressive activity of the PGC1\u03b1\/ERR\u03b1 complex. Specifically,\n                    <jats:italic>EGLN1<\/jats:italic>\n                    silencing partially reverts PGC1\u03b1-mediated PCa tumor suppressive properties both\n                    <jats:italic>in cellulo<\/jats:italic>\n                    and in vivo. Our findings are reinforced by a positive correlation between PGC1\u03b1\/ERR\u03b1 activity and\n                    <jats:italic>EGLN1<\/jats:italic>\n                    expression levels in human PCa datasets. Altogether, these results support that PHD2-regulated degradation of HIF\u03b1 contributes to PGC1\u03b1\/ERR\u03b1-mediated PCa suppression.\n                  <\/jats:p>","DOI":"10.1038\/s41418-026-01858-8","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:50:48Z","timestamp":1789667448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PGC1\u03b1-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-6831","authenticated-orcid":false,"given":"Maider","family":"Fagoaga-Eugui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Martin-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-5195","authenticated-orcid":false,"given":"Amaia","family":"Zabala-Letona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oihana","family":"Iriondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Talamillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorea","family":"Valcarcel-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarnaci\u00f3n","family":"P\u00e9rez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onintza","family":"Carlivaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saioa","family":"Garcia-Longarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Medina-Jover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4252-1977","authenticated-orcid":false,"given":"Veronica","family":"Torrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5957-1260","authenticated-orcid":false,"given":"Arkaitz","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-5744","authenticated-orcid":false,"given":"Edurne","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"1858_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"1858_CR2","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"1858_CR3","doi-asserted-by":"crossref","unstructured":"Hanahan D. Hallmarks of cancer\u2014then and now, and beyond. Cell. 2026;189:2254\u201377.","DOI":"10.1016\/j.cell.2025.12.049"},{"key":"1858_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","volume":"21","author":"I Mart\u00ednez-Reyes","year":"2021","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Cancer metabolism: looking forward. Nat Rev Cancer. 2021;21:669\u201380.","journal-title":"Nat Rev Cancer"},{"key":"1858_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","volume":"6","author":"M Demicco","year":"2024","unstructured":"Demicco M, Liu XZ, Leithner K, Fendt SM. Metabolic heterogeneity in cancer. Nat Metab. 2024;6:18\u201338.","journal-title":"Nat Metab"},{"key":"1858_CR6","doi-asserted-by":"crossref","unstructured":"Lasorsa F, di Meo NA, Rutigliano M, Ferro M, Terracciano D, Tataru OS, et al. Emerging hallmarks of metabolic reprogramming in prostate cancer. Int J Mol Sci. 2023;24:910.","DOI":"10.3390\/ijms24020910"},{"key":"1858_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","volume":"131","author":"M Pujana-Vaquerizo","year":"2024","unstructured":"Pujana-Vaquerizo M, Bozal-Basterra L, Carracedo A. Metabolic adaptations in prostate cancer. Br J Cancer. 2024;131:1250\u201362.","journal-title":"Br J Cancer"},{"key":"1858_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ncb3357","volume":"18","author":"V Torrano","year":"2016","unstructured":"Torrano V, Valcarcel-Jimenez L, Rosa Cortazar A, Liu X, Urosevic J, Castillo-Martin M, et al. The metabolic co-regulator PGC1\u03b1 suppresses prostate cancer metastasis. Nat Cell Biol. 2016;18:645\u201356.","journal-title":"Nat Cell Biol"},{"key":"1858_CR9","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1158\/0008-5472.CAN-18-2043","volume":"79","author":"L Kaminski","year":"2019","unstructured":"Kaminski L, Torrino S, Dufies M, Djabari Z, Haider R, Roustan FR, et al. PGC1\u03b1 inhibits polyamine synthesis to suppress prostate cancer aggressiveness. Cancer Res. 2019;79:3268\u201380.","journal-title":"Cancer Res"},{"key":"1858_CR10","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1158\/0008-5472.CAN-19-1231","volume":"79","author":"L Valcarcel-Jim\u00e9nez","year":"2019","unstructured":"Valcarcel-Jim\u00e9nez L, Macchia A, Crosas-Molist E, Schaub-Clerigue A, Camacho L, Mart\u00edn-Mart\u00edn N, et al. PGC1a suppresses prostate cancer cell invasion through ERRA transcriptional control. Cancer Res. 2019;79:6153\u201365.","journal-title":"Cancer Res"},{"key":"1858_CR11","doi-asserted-by":"crossref","unstructured":"Schaub-Clerigu\u00e9 A, Hermanova I, Pintor-Rial A, Sydorenko M, Valcarcel-Jim\u00e9nez L, Macchia A, et al. Secreted spermidine synthase reveals a paracrine role for PGC1\u03b1-induced growth suppression in prostate cancer. Cell Death Dis. 2025;16:330.","DOI":"10.1038\/s41419-025-07639-4"},{"key":"1858_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"1858_CR13","doi-asserted-by":"crossref","unstructured":"Brahimi-Horn C, Berra E, Pouyss\u00e9gur J. Hypoxia: The tumor\u2019s gateway to progression along the angiogenic pathway. Trends Cell Biol. 2001;11:S32\u20136.","DOI":"10.1016\/S0962-8924(01)82185-1"},{"key":"1858_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"1858_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.04.019","volume":"31","author":"L Yang","year":"2018","unstructured":"Yang L, Roberts D, Takhar M, Erho N, Bibby BAS, Thiruthaneeswaran N, et al. Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer. EBioMedicine. 2018;31:182\u20139.","journal-title":"EBioMedicine"},{"key":"1858_CR16","doi-asserted-by":"crossref","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Investig. 2022;132:e159839.","DOI":"10.1172\/JCI159839"},{"key":"1858_CR17","doi-asserted-by":"publisher","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","volume":"95","author":"LE Huang","year":"1998","unstructured":"Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1858_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wlesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271\u20135.","journal-title":"Nature"},{"key":"1858_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464\u20138.","journal-title":"Science"},{"key":"1858_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468\u201372.","journal-title":"Science"},{"key":"1858_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"ACR Epstein","year":"2001","unstructured":"Epstein ACR, Gleadle JM, McNeill LA, Hewitson KS, O\u2019Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43\u201354.","journal-title":"Cell"},{"key":"1858_CR22","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337\u201340.","journal-title":"Science"},{"key":"1858_CR23","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra E, Benizri E, Ginouv\u00e8s A, Volmat V, Roux D, Pouyss\u00e9gur J. Pouyss\u00e9gur, HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 2003;22:4082\u201390.","journal-title":"EMBO J"},{"key":"1858_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cell.2004.08.025","volume":"118","author":"D Gerald","year":"2004","unstructured":"Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell. 2004;118:781\u201394.","journal-title":"Cell"},{"key":"1858_CR25","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard PJ, Bri\u00e8re JJ, Alam NA, Barwell J, Barclay E, Wortham NC, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005;14:2231\u20139.","journal-title":"Hum Mol Genet"},{"key":"1858_CR26","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1158\/0008-5472.CAN-13-2893-T","volume":"74","author":"JH Lim","year":"2014","unstructured":"Lim JH, Luo C, Vazquez F, Puigserver P. Targeting mitochondrial oxidative metabolism in melanoma causes metabolic compensation through glucose and glutamine utilization. Cancer Res. 2014;74:3535\u201345.","journal-title":"Cancer Res"},{"key":"1858_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of PTEN-deficient tumorigenesis. Nature. 2005;436:725\u201330.","journal-title":"Nature"},{"key":"1858_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/ijc.22436","volume":"120","author":"C Trastour","year":"2007","unstructured":"Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyss\u00e9gur J, et al. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer. 2007;120:1451\u20138.","journal-title":"Int J Cancer"},{"key":"1858_CR29","doi-asserted-by":"publisher","first-page":"6320","DOI":"10.1158\/0008-5472.CAN-18-1669","volume":"78","author":"AR Cortazar","year":"2018","unstructured":"Cortazar AR, Torrano V, Mart\u00edn-Mart\u00edn N, Caro-Maldonado A, Camacho L, Hermanova I, et al. CANCERTOOL: a Visualization and Representation Interface to Exploit Cancer Datasets. Cancer Res. 2018;78:6320\u20138.","journal-title":"Cancer Res"},{"key":"1858_CR30","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1021\/jm049334f","volume":"47","author":"BB Busch","year":"2004","unstructured":"Busch BB, Stevens WC, Martin R, Ordentlich P, Zhou S, Sapp DW, et al. Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha. J Med Chem. 2004;47:5593\u20136.","journal-title":"J Med Chem"},{"key":"1858_CR31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1259\/bjr\/25046649","volume":"80","author":"CB Westbury","year":"2007","unstructured":"Westbury CB, Pearson A, Nerurkar A, Reis-Filho JS, Steele D, Peckitt C, et al. Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. Br J Radiol. 2007;80:934\u20138.","journal-title":"Br J Radiol"},{"key":"1858_CR32","doi-asserted-by":"crossref","unstructured":"Park CH, Park M, Kelly ME, Cheng H, Lee SR, Jang C, Chang JS, et al. Cold-inducible GOT1 activates the malate-aspartate shuttle in brown adipose tissue to support fuel preference for fatty acids. Cell Rep. 2025;44:115888.","DOI":"10.1016\/j.celrep.2025.115888"},{"key":"1858_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11\u201322.","journal-title":"Cancer Cell"},{"key":"1858_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser M, Sabelnykova VY, Yamaguchi TN, Heisler LE, Livingstone J, Huang V, et al. Genomic hallmarks of localized, non-indolent prostate cancer. Nature. 2017;541:359\u201364.","journal-title":"Nature"},{"key":"1858_CR35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","volume":"161","author":"D Robinson","year":"2015","unstructured":"Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161:1215\u201328.","journal-title":"Cell"},{"key":"1858_CR36","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/cr.2010.46","volume":"20","author":"L Zhu","year":"2010","unstructured":"Zhu L, Wang Q, Zhang L, Fang Z, Zhao F, Lv Z, et al. Hypoxia induces PGC-1\u03b1 expression and mitochondrial biogenesis in the myocardium of TOF patients. Cell Res. 2010;20:676\u201387.","journal-title":"Cell Res"},{"key":"1858_CR37","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/cells11142193","volume":"11","author":"I Rabinovich-Nikitin","year":"2022","unstructured":"Rabinovich-Nikitin I, Blant A, Dhingra R, Kirshenbaum LA, Czubryt MP. NF-\u03baB p65 attenuates cardiomyocyte PGC-1\u03b1 expression in hypoxia. Cells. 2022;11:2193.","journal-title":"Cells"},{"key":"1858_CR38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Z Arany","year":"2008","unstructured":"Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature. 2008;451:1008\u201312.","journal-title":"Nature"},{"key":"1858_CR39","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1073\/pnas.0808801106","volume":"106","author":"KA O\u2019Hagan","year":"2009","unstructured":"O\u2019Hagan KA, Cocchiglia S, Zhdanov AV, Tambawala MM, Cummins EP, Monfared M, et al. PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc Natl Acad Sci USA. 2009;106:2188\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1858_CR40","doi-asserted-by":"publisher","first-page":"1383809","DOI":"10.3389\/fonc.2024.1383809","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Peng J, Yang D, Xing Z, Jiang B, Ding X, et al. From metabolism to malignancy: the multifaceted role of PGC1\u03b1 in cancer. Front Oncol. 2024;14:1383809.","journal-title":"Front Oncol"},{"key":"1858_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cmet.2017.09.006","volume":"26","author":"S Andrzejewski","year":"2017","unstructured":"Andrzejewski S, Klimcakova E, Johnson RM, Tabari\u00e8s S, Annis MG, McGuirk S, et al. PGC-1\u03b1 promotes breast cancer metastasis and confers bioenergetic flexibility against metabolic drugs. Cell Metab. 2017;26:778\u201387.e5.","journal-title":"Cell Metab"},{"key":"1858_CR42","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.cmet.2015.08.015","volume":"22","author":"P Sancho","year":"2015","unstructured":"Sancho P, Burgos-Ramos E, Tavera A, Bou Kheir T, Jagust P, Schoenhals M, et al. MYC\/PGC-1\u03b1 balance determines the metabolic phenotype and plasticity of pancreatic cancer stem cells. Cell Metab. 2015;22:590\u2013605.","journal-title":"Cell Metab"},{"key":"1858_CR43","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1038\/s41388-023-02762-y","volume":"42","author":"W Chen","year":"2023","unstructured":"Chen W, Zhang Q, Dai X, Chen X, Zhang C, Bai R, et al. PGC-1\u03b1 promotes colorectal carcinoma metastasis through regulating ABCA1 transcription. Oncogene. 2023;42:2456\u201370.","journal-title":"Oncogene"},{"key":"1858_CR44","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1158\/0008-5472.CAN-11-1011","volume":"71","author":"K Bhalla","year":"2011","unstructured":"Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel W, Fang HBin, et al. PGC1\u03b1 promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res. 2011;71:6888.","journal-title":"Cancer Res"},{"key":"1858_CR45","doi-asserted-by":"publisher","first-page":"7754","DOI":"10.1002\/cam4.2637","volume":"8","author":"T Guo","year":"2019","unstructured":"Guo T, Li B, Gu C, Chen X, Han M, Liu X, et al. PGC-1\u03b1 inhibits polyamine metabolism in Cyclin E1-driven ovarian cancer. Cancer Med. 2019;8:7754\u201361.","journal-title":"Cancer Med"},{"key":"1858_CR46","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","volume":"29","author":"G Gentric","year":"2019","unstructured":"Gentric G, Kieffer Y, Mieulet V, Goundiam O, Bonneau C, Nemati F, et al. PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab. 2019;29:156\u201373.e10.","journal-title":"Cell Metab"},{"key":"1858_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.celrep.2015.06.006","volume":"12","author":"EL LaGory","year":"2015","unstructured":"LaGory EL, Wu C, Taniguchi CM, Ding CKC, Chi JT, von Eyben R, et al. Suppression of PGC-1\u03b1 is critical for reprogramming oxidative metabolism in renal cell carcinoma. Cell Rep. 2015;12:116.","journal-title":"Cell Rep"},{"key":"1858_CR48","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","volume":"23","author":"R Haq","year":"2013","unstructured":"Haq R, Shoag J, Andreu-Perez P, Yokoyama S, Edelman H, Rowe GC, et al. Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF. Cancer Cell. 2013;23:302\u201315.","journal-title":"Cancer Cell"},{"key":"1858_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","volume":"23","author":"F V\u00e1zquez","year":"2013","unstructured":"V\u00e1zquez F, Lim JH, Chim H, Bhalla K, Girnun G, Pierce K, et al. PGC1\u03b1 expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell. 2013;23:287\u2013301.","journal-title":"Cancer Cell"},{"key":"1858_CR50","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature19347","volume":"537","author":"C Luo","year":"2016","unstructured":"Luo C, Lim JH, Lee Y, Granter SR, Thomas A, Vazquez F, et al. A PGC1\u03b1-mediated transcriptional axis suppresses melanoma metastasis. Nature. 2016;537:422\u20136.","journal-title":"Nature"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01858-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01858-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:50:57Z","timestamp":1789667457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01858-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":50,"alternative-id":["1858"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01858-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}